Quick Dispatch:
Your tirzepatide hfpef trial SUMMIT: Tirzepatide a 'Huge Win' for HFpEF Patients With Obesity orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide hfpef trial SUMMIT: Tirzepatide a 'Huge Win' for HFpEF Patients With Obesity ships.
Need Help?
Questions about tirzepatide hfpef trial SUMMIT: Tirzepatide a 'Huge Win' for HFpEF Patients With Obesity, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide hfpef trial SUMMIT: Tirzepatide a 'Huge Win' for HFpEF Patients With Obesity in your area.
An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists
28.36
In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial https://t.co/8ZHm4gySiL
25.05
🔴In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial🩺⤵️ 🔹Tirzepatide showed: ⬇️ 38% risk HF events ⬇️56%
25.68
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
28.30
Overview of key tirzepatide clinical trials and their cardiovascular
20.32
In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial https://t.co/8ZHm4gySiL
21.85
ESC 2025: study supports use of semaglutide, tirzepatide in cardiometabolic HFpEF patients
21.16
